Zealand Pharma — Juni 2024
-
-
-
Godmorgen

-
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
-
The new shares will be issued at a subscription price of DKK 843 per new share. The aggregate gross proceeds from the issue will amount to USD 1 billion / DKK 7 billion and Zealand intends to use the net proceeds to advance Zealand’s proprietary obesity programs in Phase 2b clinical trials and beyond, including investment in associated CMC activities, and pursue clinical development in related indications with the potential to provide additional therapeutic benefits to patients.
-
The net proceeds
26/6 2024 05:55
are also expected to support continued early-stage research and fund general corporate purposes. -
Zealand Pharma henter nye penge: Vildt, bemærkelsesværdigt, usædvanligt! https://proinvestor.com/boards/121078
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1177634/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Flot at de så hurtigt henter så stort et beløb. Det sender et godt signal til omverden. Modsat så kan jeg godt være lidt nervøs for de begynder at få "lidt for store drømme". At de selv vil tage et fedme stof ind i fase 3. Jeg mener de har brug for en partner inden fase 3. Ellers bliver udviklingen alt for langsom. Kun de helt store har org/erfaring og penge til at starte mange fase 3 forsøg på kort tid. Og det er det der skal til
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind